AstraZeneca Seeks To Halt Mylan's 2nd Seroquel ANDA
AstraZeneca Pharmaceuticals Inc. has launched its second patent infringement suit against Mylan Pharmaceuticals Inc. in response to the generic-drug maker's most recent bid for regulatory approval to manufacture a copycat version...To view the full article, register now.
Already a subscriber? Click here to view full article